Hiderou Yoshida
University of Hyogo
H-index: 47
Asia-Japan
Top articles of Hiderou Yoshida
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
The cholesterol pathway of the Golgi stress response induces cell death and transcription of Golgi-related genes through metabolic dysregulation of phosphatidylinositol-4-phosphate | bioRxiv | Kanae Sasaki Takuya Adachi Fumi Morishita Marika Toide Yuto Watanabe | 2023 |
Expression of transcription factors KLF2 and KLF4 is induced by the mammalian Golgi stress response | bioRxiv | Kanae Sasaki Miyu Sakamoto Iona Miyake Reishi Tanaka Ryuya Tanaka | 2023 |
EE63 Cost-Effectiveness of Olaparib Plus Bevacizumab First-Line Maintenance in Ovarian Cancer Alongside the PAOLA-1 Trial | L Perrier K Zarca T Cadet M Morelle C Cropet | 2023/12/1 | |
786P Antitumor activity of farletuzumab ecteribulin in a panel of endometrial cancer patient-derived xenografts with four different molecular subtypes | Annals of Oncology | K Hasegawa S Yagishita D Shintani H Yoshida M Suzuki | 2023/10/1 |
Phosphorylation of EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha) is indispensable for nuclear translocation of TFEB and TFE3 during ER stress | Autophagy | Thao Thi Dang Mi-Jeong Kim Yoon Young Lee Hien Thi Le Kook Hwan Kim | 2023/7/3 |
Signal sequence-triage is activated by translocon obstruction sensed by an ER stress sensor IRE1α | Cell Structure and Function | Ashuei Sogawa Ryota Komori Kota Yanagitani Miku Ohfurudono Akio Tsuru | 2023 |
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma | Chiharu Mizoguchi Tadaaki Nishikawa Hiroshi Yoshida Kasumi Yamamoto Rui Kitadai | 2022/12/21 | |
LBA29 Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly … | Annals of Oncology | IL Ray-Coquard A Leary S Pignata C Cropet AJ Gonzalez Martin | 2022/9/1 |
P-384 Efficacy of endometrial microbiome metagenomic analysis with recurrent implantation failure and recurrent pregnancy loss: multicenter study in Japan | Human Reproduction | N Iwami S Komiya Y Asada K Tatsumi T Habara | 2022/7/1 |
Förster resonance energy transfer (FRET) nanoprobe could diagnose pancreatic juice activation due to postoperative pancreatic fistula | HPB | S Mizutani M Murata H Furuki R Nakata N Taniai | 2021/1/1 |
1767P Co-clinical PDX study of trastuzumab deruxtecan in HER2-positive uterine carcinosarcoma (STATICE trial, NCCH1615) | Annals of Oncology | S Yagishita T Nishikawa H Yoshida D Shintani S Sato | 2021/9/1 |
813P efficacy and safety of trastuzumab deruxtecan in HER2-expressing uterine carcinosarcoma (STATICE trial, NCCH1615): a multicenter, phase II clinical trial | Annals of Oncology | K Hasegawa T Nishikawa A Hirakawa M Kawasaki S Tomatsuri | 2021/9/1 |
739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged≥ 65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial | Annals of oncology | Renaud Sabatier F Rousseau F Joly C Cropet C Montegut | 2021/9/1 |
FP07. 04 Predictive Efficacy of Morphological Biomarkers Based on Digital Pathology for ICI Therapy of Non-Small Cell Lung Cancer | Journal of Thoracic Oncology | N Motoi H Yoshida T Kiyuna H Saiga H Horinouchi | 2021/3/1 |
Snowmass2021-Letter of Interest Ocean Bottom Detector | snowmass loi | H Watanabe K Inoue T Sakai WF McDonough N Abe | 2021 |
P-283 Analysis of KRAS mutation allele in circulating cell-free DNA derived from urine in colorectal cancer patients | Annals of Oncology | R Ohta T Yamada S Shinji A Matsuda G Takahashi | 2020/7/1 |